The effect of Toll-like receptor stimulation on the motility of regulatory T cells.
Current and future therapies for type 1 diabetes.
Multicomponent plasmid protects mice from spontaneous autoimmune diabetes.
Current state of antigen-specific immunotherapy for type 1 diabetes.
Peripheral autoreactive CD8 T-cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes.
IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
How benign autoimmunity becomes detrimental in type 1 diabetes.
A cold case no longer
What happened when an LJI scientist revisited a diabetes mystery